Brigitte AGL van Cleef
Brigitte AGL van Cleef
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,✉,
Dominique L Monnet
Dominique L Monnet
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Andreas Voss
Andreas Voss
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Karina Krziwanek
Karina Krziwanek
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Franz Allerberger
Franz Allerberger
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Marc Struelens
Marc Struelens
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Helena Zemlickova
Helena Zemlickova
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Robert L Skov
Robert L Skov
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Jaana Vuopio-Varkila
Jaana Vuopio-Varkila
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Christiane Cuny
Christiane Cuny
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Alexander W Friedrich
Alexander W Friedrich
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Iris Spiliopoulou
Iris Spiliopoulou
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Judit Pászti
Judit Pászti
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Hjordis Hardardottir
Hjordis Hardardottir
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Angela Rossney
Angela Rossney
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Angelo Pan
Angelo Pan
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Annalisa Pantosti
Annalisa Pantosti
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Michael Borg
Michael Borg
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Hajo Grundmann
Hajo Grundmann
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Manica Mueller-Premru
Manica Mueller-Premru
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Barbro Olsson-Liljequist
Barbro Olsson-Liljequist
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Andreas Widmer
Andreas Widmer
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Stephan Harbarth
Stephan Harbarth
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Alexander Schweiger
Alexander Schweiger
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Serhat Unal
Serhat Unal
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,
Jan AJW Kluytmans
Jan AJW Kluytmans
1Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann);
2VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans);
3European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet);
4Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss);
5Elisabethinen Hospital, Linz, Austria (K. Krziwanek);
6Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger);
7Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens);
8Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova);
9Statens Serum Institut, Copenhagen, Denmark (R.L. Skov);
10National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila);
11Robert Koch Institute, Wernigerode, Germany (C. Cuny);
12Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich);
13University of Patras, Patras, Greece (I. Spiliopoulou);
14National Center for Epidemiology, Budapest, Hungary (J. Pászti);
15Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir);
16National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney);
17Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan);
18Istituto Superiore di Sanità, Rome, Italy (A. Pantosti);
19Mater Dei Hospital, Msida, Malta (M. Borg);
20Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru);
21Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist);
22University Hospital, Basel, Switzerland (A. Widmer);
23Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth);
24University Hospital Zürich, Zürich, Switzerland (A. Schweiger);
25Hacettepe University, Ankara, Turkey (S. Unal);
26Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26